Announcements/News
Neumentum, Inc. Nominated for Two Citeline Awards
Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that it has been nominated for two Informa Pharma Intelligence Citeline Awards including the Most Successful Early Stage Research and Clinical Trial Result of the Year categories.
Continuous Ketorolac Infusion Formulation Predicted to Provide Rapid-Onset Pain Relief
There is strong evidence that a continuous infusion formulation of ketorolac (NTM-001, Neumentum) achieves a fast onset of effective analgesia that is maintained at a stable level over 24 hours, based on initial results of a phase 1 trial and a PubMed literature review of infusion trials in a variety of major surgical procedures.
Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at BIO CEO and Investor Conference in New York
Scott Shively, Chief Executive Officer, will present at the BIO CEO and Investor Conference held February, 10 – 11, 2020 at the Marriot Marquis in New York City
Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at 2020 Biotech Showcase in San Francisco, CA
Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2020 Biotech Showcase being held January 13-15, 2020 in San Francisco, CA.
Neumentum, Inc. Executive Chairman, Joseph Pergolizzi, Jr., M.D. and Chief Scientific Officer, Robert Raffa, Ph.D. To Present at 2019 Pain Summit in Philadelphia, PA
Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Joseph Pergolizzi, Jr., M.D. and Robert Raffa, Ph.D., will both present keynote speeches at the upcoming Pain Summit being held November 19-20th in Philadelphia, PA.
Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at 2019 BIO Investor Forum in San Francisco, CA
Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2019 BIO Investor Forum being held October 22 – 23, 2019 in San Francisco, CA.
Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at 2019 BIO International Convention in Philadelphia, PA
PALO ALTO, Calif., May 15, 2019 – Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2019 BIO International Convention being held...
Joseph Pergolizzi, MD, co-founder and executive chairman of Neumentum, recognized as a 2018 Top Doctor
Joseph Pergolizzi, MD, of Naples Anesthesia & Pain Associates, Inc., has been named a 2018 Top Doctor nationally. The Top Doctor Awards program is dedicated to...
All rights reserved, including copyright 2020, Neumentum, Inc